---
type: "Nootropic"
title: "L-Tyrosine"
description: "L-Tyrosine is an amino acid used in catecholamine synthesis. Small, variable human experiments studied selected tasks under stress; they do not establish general cognitive enhancement, a personal dose or equivalence with NALT."
resource: "https://nootropikler.com/nootropics/l-tyrosine"
tags: ["Stress", "Amino Acid"]
timestamp: 2026-11-11T00:00:00Z
category: "cognitive"
source: "Natural"
latin: "L-Tyrosine"
language: "en"
---

# L-Tyrosine

*L-Tyrosine*

L-Tyrosine is an amino acid used in catecholamine synthesis. Small, variable human experiments studied selected tasks under stress; they do not establish general cognitive enhancement, a personal dose or equivalence with NALT.

## Quick profile

| Property | Value |
| --- | --- |
| Onset of Effect | No established timeframe |
| Dose used in research | Depends on the studied product and protocol |
| Safety | See detailed safety warnings |

> 2026-11-11 correction: Cold and sleep-loss experiments were bounded to their conditions; narrative review was distinguished from systematic review. The generic half-life and dose unverified in the sources read were removed. Phenelzine contraindication and levodopa absorption warnings were linked to drug labels; NALT-superiority advice was removed.

## What is L-Tyrosine?

L-Tyrosine is an amino acid used in catecholamine synthesis. Small, variable human experiments studied selected tasks under stress; they do not establish general cognitive enhancement, a personal dose or equivalence with NALT.

## Clinical Evidence

Shurtleff et al. (1994) examined working memory in the cold in 8 male volunteers using 150 mg/kg L-tyrosine and found benefit on one task measure. This small experiment does not validate a standard 500–2000 mg dose for healthy people or benefit under all stress conditions.

Limited to eight men and one cold-task protocol; no task effect was seen at 22 °C. The 150 mg/kg research amount cannot become a standard daily dose. The accessed abstract did not verify randomization, so no RCT label was assigned.

Neri et al. (1995) compared a split 150 mg/kg L-tyrosine amount with placebo under double blinding during one night of sleep loss. Benefits on selected psychomotor and vigilance tasks lasted approximately three hours.

A three-hour task difference is not plasma half-life, a sleep substitute or personal timing. The accessed abstract does not verify randomization; this experiment does not establish everyday performance, effects under all stressors or long-term safety.

The Jongkees et al. (2015) narrative review describes variable L-tyrosine findings and possible benefits related to short-term stress or cognitive demands. Potential for clinical disease treatment and physical exercise was judged more limited.

This is a narrative review, not a pooled-effect meta-analysis or oral comparison with NALT. Being a biochemical precursor does not guarantee increased dopamine or clinical benefit for everyone.

## L-Tyrosine vs N-Acetyl-L-Tyrosine (NALT)

The Jongkees et al. (2015) review concerns L-tyrosine supplementation. The abstract read does not establish oral NALT cognitive superiority, faster effects or use at the same dose as L-tyrosine.

A parent-compound experiment cannot automatically establish clinical efficacy of its acetylated derivative. This limited reading does not claim all NALT research is absent; distinguish a research question from a demonstrated result.

## Dose information and research limits

> **Dose information and research limits:** This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

## Safety and Side Effects

The phenelzine label explicitly lists L-tyrosine among substances that should not be taken together, with a hypertensive-crisis warning. The carbidopa/levodopa label describes competition with certain amino acids for intestinal transport and reduced absorption with high-protein diets.

These labels concern the named medicines, not equal evidence for every MAOI, supplement dose or NALT. Do not change prescribed medication; review combined use with a doctor or pharmacist. This information does not generate personal medication times.

Tyrosine is not prohibited in PKU; reduced production from phenylalanine can make it part of specialist-managed nutrition. Do not self-adjust extra tyrosine doses; it does not replace standard PKU treatment.


## Frequently Asked Questions

### What does L-Tyrosine do?

L-Tyrosine is an amino acid used in catecholamine synthesis. Small, variable human experiments studied selected tasks under stress; they do not establish general cognitive enhancement, a personal dose or equivalence with NALT.

### How many mg of L-Tyrosine should be taken per day?

Shurtleff et al. (1994) examined working memory in the cold in 8 male volunteers using 150 mg/kg L-tyrosine and found benefit on one task measure. This small experiment does not validate a standard 500–2000 mg dose for healthy people or benefit under all stress conditions.

### Should L-Tyrosine or NALT be preferred?

The Jongkees et al. (2015) review concerns L-tyrosine supplementation. The abstract read does not establish oral NALT cognitive superiority, faster effects or use at the same dose as L-tyrosine.

### Does L-Tyrosine work against sleep deprivation?

A three-hour task difference is not plasma half-life, a sleep substitute or personal timing. The accessed abstract does not verify randomization; this experiment does not establish everyday performance, effects under all stressors or long-term safety.

## Sources

- Shurtleff D, et al. (1994). Tyrosine reverses a cold-induced working memory deficit in humans. *Pharmacology Biochemistry and Behavior*, 47(4), 935–941. [PubMed · PMID 8029265](https://pubmed.ncbi.nlm.nih.gov/8029265/)
- Neri DF, et al. (1995). The effects of tyrosine on cognitive performance during extended wakefulness. *Aviation, Space, and Environmental Medicine*, 66(4), 313–319. [PubMed · PMID 7794222](https://pubmed.ncbi.nlm.nih.gov/7794222/)
- Deijen JB, Orlebeke JF. (1994). Effect of tyrosine on cognitive function and blood pressure under stress. *Brain Research Bulletin*, 33(3), 319–323. [PubMed · PMID 8293316](https://pubmed.ncbi.nlm.nih.gov/8293316/)
- Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands--A review. *Journal of Psychiatric Research*, 70, 50–57. [PubMed · PMID 26424423](https://pubmed.ncbi.nlm.nih.gov/26424423/)
- van Wegberg AMJ, et al. (2017). The complete European guidelines on phenylketonuria: diagnosis and treatment. *Orphanet Journal of Rare Diseases*, 12(1), 162. https://doi.org/10.1186/s13023-017-0685-2 [PubMed · PMID 29025426](https://pubmed.ncbi.nlm.nih.gov/29025426/)
- DailyMed. Phenelzine sulfate: US prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa041652-fdde-4794-a8d2-279dd309e075 [DailyMed / US National Library of Medicine](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa041652-fdde-4794-a8d2-279dd309e075)
- DailyMed. Carbidopa and levodopa: US prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f6d393e-ac84-4a3c-a837-199d1ec71fd2 [DailyMed / US National Library of Medicine](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f6d393e-ac84-4a3c-a837-199d1ec71fd2)

## Related nootropics

- [N-Acetyl L-Tyrosine](/okf/nootropics/n-acetyl-l-tyrosine.md)
- [rhodiola rosea](/okf/nootropics/rhodiola-rosea.md)
- [Mucuna Pruriens](/okf/nootropics/mucuna-pruriens.md)
